Hematopathology Practice Questions

Q: What is the most common site of histiocytosis?

Bone. **Explanation:** **Langerhans Cell Histiocytosis (LCH)**, formerly known as Histiocytosis X, is a proliferative disorder of dendritic cells (Langerhans cells) [1]. **1. Why Bone is the Correct Answer:** Bone is the most frequently involved organ in LCH, occurring in approximately **80% of cases**. It typically presents as a **solitary osteolytic lesion** (Eosinophilic Granuloma), most commonly involving the **skull**, followed by the femur, ribs, and mandible. In pediatric populations, it is a classic cause of a "punched-out" radiolucent lesion on a skull X-ray. **2. Why Other Options are Incorrect:** * **B. Skin:** This is the second most common site (approx. 30-40%). It often presents as a seborrheic dermatitis-like rash, especially in the Letterer-Siwe disease variant. * **C. Lung:** While common in adult smokers (Pulmonary LCH), it is less frequent than bone involvement across the general disease spectrum. * **D. Liver:** Involvement of the liver, spleen, or bone marrow indicates "high-risk" multisystem disease (Letterer-Siwe) but is statistically less common than skeletal involvement. **3. NEET-PG High-Yield Pearls:** * **Pathognomonic Marker:** **Birbeck Granules** (tennis-racket shaped pentalaminar structures) seen on Electron Microscopy [1]. * **Immunohistochemistry (IHC):** Positive for **CD1a**, **S100**, and **Langerin (CD207)** [1]. Langerin is the most specific marker. * **Clinical Triad (Hand-Schüller-Christian disease):** Calvarial bone defects, Exophthalmos, and Diabetes Insipidus. * **Mutation:** Frequently associated with the **BRAF V600E** mutation (approx. 50% of cases) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 629-630.

Q: Which of the following is false regarding Chediak-Higashi syndrome?

It is inherited in an autosomal dominant pattern.. **Explanation:** **Chediak-Higashi Syndrome (CHS)** is a rare, multisystem disorder caused by a mutation in the **LYST gene** (Lysosomal Trafficking Regulator). 1. **Why Option A is the correct answer (False statement):** Chediak-Higashi syndrome is inherited in an **autosomal recessive** pattern, not autosomal dominant [1]. The mutation leads to defective vesicle fusion and intracellular protein trafficking, resulting in the formation of pathognomonic **giant granules** in various cells [1]. 2. **Why the other options are true:** * **Option B:** The primary cellular defect is the failure of **phagosome-lysosome fusion** [1]. This prevents the effective killing of phagocytosed bacteria, leading to recurrent pyogenic infections (primarily by *Staphylococcus* and *Streptococcus*). * **Option C:** Melanocytes are affected because **melanosomes** (specialized lysosomes) fail to distribute melanin properly [1]. This results in **oculocutaneous albinism**, a hallmark clinical feature. * **Option D:** Platelets contain "dense bodies" (delta granules) which are lysosome-like organelles. Defective trafficking leads to a **storage pool deficiency**, resulting in platelet dysfunction and bleeding tendencies [1]. **NEET-PG High-Yield Pearls:** * **Peripheral Smear:** Look for **giant peroxidase-positive granules** in neutrophils and precursors [1]. * **Clinical Tetrad:** Partial albinism, recurrent infections, peripheral neuropathy, and mild bleeding [1]. * **Accelerated Phase:** A life-threatening "lymphoma-like" syndrome characterized by hemophagocytic lymphohistiocytosis (HLH), hepatosplenomegaly, and pancytopenia. * **Diagnosis:** Confirmed by genetic testing (LYST gene) or seeing giant granules on a blood film [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 245-246.

Q: The arrow shows:

Cabot's rings seen in pernicious anemia. ***Cabot's rings seen in pernicious anemia*** - **Cabot's rings** are thin, blue to purple ring-like or figure-of-eight structures within red blood cells, representing remnants of the **mitotic spindle**. - They are classically associated with **megaloblastic anemia**, particularly **pernicious anemia**, due to impaired DNA synthesis from **B12/folate deficiency**. *Howell-Jolly bodies seen in pernicious anemia* - **Howell-Jolly bodies** are small, round **nuclear remnants** (DNA fragments) that appear as dark purple inclusions in red blood cells. - They are primarily associated with **asplenia** or **splenic dysfunction**, not specifically with pernicious anemia morphology. *Rushton bodies seen in iron deficiency anemia* - **Rushton bodies** are **eosinophilic hyaline bodies** found in **odontogenic cysts**, particularly radicular cysts, not in blood cells. - They are completely unrelated to **hematological conditions** and have no association with iron deficiency anemia. *None of the above* - This option is incorrect as **Cabot's rings** are indeed the correct identification of the arrow-indicated structure. - The morphological description and clinical association with **pernicious anemia** make this option inappropriate.

Q: Which is the most common antigen implicated in hemolytic disease of the newborn?

D antigen in Rh group. **Explanation:** Hemolytic Disease of the Newborn (HDN) occurs due to the transplacental passage of maternal IgG antibodies that target fetal red blood cell antigens, leading to hemolysis. **Why Option B is Correct:** The **D antigen** of the Rh blood group system is the most potent immunogen among all human blood group antigens. Rh incompatibility occurs when an Rh-negative mother (d/d) carries an Rh-positive fetus (D/d). Sensitization usually happens during delivery; in subsequent pregnancies, maternal anti-D antibodies cross the placenta, causing immune-mediated hemolysis. Despite the use of Anti-D prophylaxis (RhoGAM), the D antigen remains the **most common and most severe** cause of significant Rh-related HDN. **Why Other Options are Incorrect:** * **Options A & C (C and E antigens):** These are "minor" Rh antigens. While they can cause HDN, they are significantly less immunogenic than the D antigen and are much rarer causes of clinical disease. * **Option D (Duffy antigen):** This is a minor blood group system. While anti-Duffy antibodies can cause HDN or transfusion reactions, they are extremely rare compared to Rh or ABO incompatibilities. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of HDN overall:** ABO incompatibility (usually Mother 'O' and Baby 'A' or 'B'). It is often milder and can occur in the first pregnancy. * **Most common cause of SEVERE HDN:** Rh (D) incompatibility. * **Standard Prophylaxis:** 300 mcg of Anti-D is given to Rh-negative unsensitized mothers at 28 weeks gestation and within 72 hours of delivery. * **Diagnosis:** The **Direct Coombs Test (DCT)** on fetal/neonatal cord blood is the gold standard for confirming immune-mediated hemolysis.

Q: What is the most common site of MALToma?

Stomach. **Explanation:** **MALToma (Mucosa-Associated Lymphoid Tissue lymphoma)** is a type of extranodal marginal zone B-cell lymphoma. Under normal physiological conditions, the stomach lacks organized lymphoid tissue. However, chronic inflammation—most commonly due to **_Helicobacter pylori_ infection**—induces the formation of acquired MALT in the gastric mucosa [1]. Chronic antigenic stimulation leads to the proliferation of B-cells, eventually resulting in neoplastic transformation. * **Stomach (Correct):** It is the **most common site** for extranodal lymphomas, accounting for approximately 50% of all cases. Within the GI tract, the stomach is the site of origin for about 85% of MALTomas [1]. * **Neck & Mediastinum (Incorrect):** While nodal lymphomas (like Hodgkin or Diffuse Large B-cell Lymphoma) frequently involve cervical or mediastinal lymph nodes, MALToma is specifically an **extranodal** entity. * **Vertebra (Incorrect):** Bone involvement is characteristic of Multiple Myeloma or metastatic disease, not MALToma. **High-Yield Clinical Pearls for NEET-PG:** * **Association:** Strongly linked to **_H. pylori_** (80% of cases) [1]. Eradication of the bacteria with antibiotics can lead to complete regression of the tumor in early stages. * **Cytogenetics:** The most common translocation is **t(11;18)(q21;q21)**, involving the *API2-MLT* gene fusion. This translocation is typically associated with resistance to _H. pylori_ eradication therapy. * **Histology:** Characterized by **lymphoepithelial lesions** (invasion of gastric glands by neoplastic B-cells). * **Markers:** CD19+, CD20+, CD22+, and **CD5- / CD10-** (helps differentiate from Mantle cell and Follicular lymphoma). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 356-357.

Q: The Fleischer assay is used for which of the following conditions?

Paroxysmal nocturnal hemoglobinuria. **Explanation:** **Paroxysmal Nocturnal Hemoglobinuria (PNH)** is an acquired clonal hematopoietic stem cell disorder characterized by a mutation in the **PIGA gene**. This mutation leads to a deficiency of Glycosylphosphatidylinositol (GPI) anchors, which are necessary to attach protective proteins like **CD55 (DAF)** and **CD59 (MIRL)** to the red blood cell membrane [1]. Without these proteins, RBCs are highly susceptible to complement-mediated lysis. The **Fleischer Assay** (also known as the **Proaerolysin variant assay**) is a specialized diagnostic test for PNH. It utilizes a fluorescently labeled, inactive variant of **Aerolysin** (a bacterial toxin from *Aeromonas hydrophila*). Unlike the traditional Ham’s test or Sucrose Hemolysis test, which are now largely obsolete, the Fleischer assay (specifically **FLAER** - Fluorescent Proaerolysin) binds directly to the GPI anchors. In PNH, the absence of these anchors results in a lack of binding, which is then detected via flow cytometry [1]. This is currently the "Gold Standard" for diagnosis due to its high sensitivity and specificity. **Why other options are incorrect:** * **Hereditary Spherocytosis:** Diagnosed via the Osmotic Fragility Test or the **EMA (Eosin-5-maleimide) binding test**. * **Thalassemia:** Diagnosed via **Hb Electrophoresis** or HPLC to identify abnormal hemoglobin chains. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard for PNH:** Flow cytometry using **FLAER**. * **Classic Triad:** Hemolytic anemia, pancytopenia, and venous thrombosis (often in unusual sites like the Budd-Chiari syndrome) [1]. * **Key Markers:** Deficiency of CD55 and CD59. * **Treatment:** Eculizumab (a monoclonal antibody against C5 complement). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 650-651.

Question 1

What is the most common site of histiocytosis?

Accepted Answer

Bone

Answer

Skin

Answer

Lung

Answer

Liver

Question 2

Which of the following is false regarding Chediak-Higashi syndrome?

Accepted Answer

It is inherited in an autosomal dominant pattern.

Answer

There is a defect in the fusion of phagosomes and lysosomes.

Answer

Abnormalities are present in melanocytes.

Answer

Platelet abnormalities are present.

Question 3

What is the expected reticulocyte count in hemolytic jaundice?

Accepted Answer

2.50%

Answer

0.50%

Answer

1%

Answer

1.50%

Question 4

The arrow shows:

Accepted Answer

Cabot's rings seen in pernicious anemia

Answer

Howell-Jolly bodies seen in pernicious anemia

Answer

Rushton bodies seen in iron deficiency anemia

Answer

None of the above

Question 5

Which is the most common antigen implicated in hemolytic disease of the newborn?

Accepted Answer

D antigen in Rh group

Answer

C antigen in Rh group

Answer

E antigen in Rh group

Answer

Duffy antigen

Question 6

What is the most common site of MALToma?

Accepted Answer

Stomach

Answer

Neck

Answer

Mediastinum

Answer

Vertebra

Question 7

The Fleischer assay is used for which of the following conditions?

Accepted Answer

Paroxysmal nocturnal hemoglobinuria

Answer

Hereditary spherocytosis

Answer

Thalassemia

Answer

All of the above

Question 8

What is the typical TIBC (Total Iron-Binding Capacity) in Anemia of chronic disease compared to Iron deficiency anemia?

Accepted Answer

Decreased in Anemia of chronic disease and increased in Iron deficiency anemia

Answer

Increased in both

Answer

Decreased in both

Answer

Increased in Anemia of chronic disease and decreased in Iron deficiency anemia

Question 9

Deficiency or inhibition by blocking antibodies of ADAMTS-13 (a metalloprotein) is found in which of the following conditions?

Accepted Answer

Thrombotic Thrombocytopenic Purpura

Answer

Idiopathic Thrombocytopenic Purpura

Answer

Henoch Schonlein Purpura

Answer

Hemophilia

Question 10

An 18-year-old patient's hemogram shows Hb 12 g/dL, RBC count of 6 million/µL, decreased MCV of 56 fL, decreased MCH of 29 pg, and RDW of 14%. What is the most probable diagnosis?

Accepted Answer

Beta-thalassemia trait

Answer

Iron deficiency

Answer

Folate deficiency

Answer

Normal laboratory parameters

Hematopathology — MCQs

Hematopathology — MCQs

On this page

Practice by Chapter

Want unlimited practice?